– SOUTH AFRICA, Stellenbosch – Mediclinic International PLC (LON: MDC | JSE: MEI | NSX: MEP), a leading diversified international private healthcare services group, today announced the appointment of Natalia Barsegiyan and Zarina Bassa to its Board as independent non-executive directors.
“The Board is delighted to welcome Natalia and Zarina as independent non-executive directors of the Company. Each will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.” said Board Chair, Dame Inga Beale.
About Natalia Barsegiyan
Natalia Barsegiyan is currently a non-executive director of Domino’s Pizza Group plc, the FTSE 250 digitally-enabled, quick service international restaurant group, and is a member of their Audit Committee. She also acts as an adviser to Kharis Capital, a private equity firm based in Belgium. Before this, the majority of Natalia’s career was with the US group Yum! Brands, Inc., owner of a portfolio of many well-known brands such as KFC, Pizza Hut, and Taco Bell, where she served as Chief Commercial Officer of the Group and then CFO of Taco Bell. Her appointment as a director of Mediclinic will become effective on 1 August 2021. Natalia will bring a strong finance background with a commercial and strategic focus, an in-depth understanding of the use of data analytics to support transformation, and broad international experience, having lived and worked across the US, Europe, Russia, and the UK.
About Zarina Bassa
Zarina Bassa is currently the senior independent director of Investec plc and Investec Ltd, the specialist banking and wealth management group with a dual-listed company structure and listings on the London and Johannesburg Stock Exchanges; lead independent director of Woolworths Holdings Ltd, and non-executive director of JSE Ltd and Oceana Group Ltd. Zarina has stepped down today as Chair of Yebo Yethu Ltd and previously served as a non-executive director at several other companies including Kumba Iron Ore Ltd; Mercedes Benz SA Ltd; Sun International Ltd; Vodacom South Africa Proprietary Limited; the South African Institute of Chartered Accountants; and the Financial Services Board. Before that, she was a partner of Ernst & Young Inc. and then joined the Absa Group in 2002, where she served as an executive director of Absa Bank, a member of the group’s executive committee, and Head of the Private Bank. Zarina’s appointment as a director of Mediclinic will become effective on 1 February 2022. The Board of Mediclinic has carefully considered Zarina’s existing time commitments and is satisfied that she will have sufficient time to dedicate to fulfill her responsibilities to the Group. She will contribute strategic and operational experience in complex, regulated environments, a strong financial and accounting background, and diverse experience in listed companies across a breadth of sectors and jurisdictions.
About Mediclinic International plc
Mediclinic is a diversified international private healthcare services group, established in South Africa in 1983, with divisions in Switzerland, Southern Africa (South Africa and Namibia), and the United Arab Emirates.
The Group’s core purpose is to enhance the quality of life.
Its vision is to be the partner of choice that people trust for all their healthcare needs.
Mediclinic is focused on providing specialist-orientated, multi-disciplinary services across the continuum of care in such a way that the Group will be regarded as the most respected and trusted provider of healthcare services by patients, medical practitioners, funders, and regulators of healthcare in each of its markets.
On 1 July 2021, Mediclinic comprised 74 hospitals, five subacute hospitals, two mental health facilities, 18-day case clinics, and 18 outpatient clinics. Hirslanden operated 17 hospitals and four-day case clinics in Switzerland with more than 1 900 inpatient beds; Mediclinic Southern Africa operations included 50 hospitals (three of which in Namibia), five sub-acute hospitals, two mental health facilities, and 12-day case clinics (four of which operated by Intercare) across South Africa, and around 8 600 inpatient beds; and Mediclinic Middle East operated seven hospitals, two-day case clinics and 18 outpatient clinics with more than 900 inpatient beds in the UAE. In addition, under management contracts, Mediclinic Middle East operates one hospital in Abu Dhabi and will open a 200-bed hospital in the Kingdom of Saudi Arabia in mid-2022.
The Company’s primary listing is on the LSE in the UK, with secondary listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia.
Mediclinic also holds a 29.9% interest in Spire Healthcare Group plc, a leading private healthcare group based in the United Kingdom and listed on the LSE.
For more information: https://www.mediclinic.com/en/home.html
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
